Elortinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elortinib, covering 2017-03-01 to 2017-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations [Phase 3]